Omaha, NE (PRWEB) March 19, 2014
HealthInterlink®, a leading provider of remote patient monitoring software applications, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Beacon® version 2.0, a flexible, affordable, and scalable software-based remote patient monitoring solution.
Beacon’s software incorporates FDA cleared, wireless patient monitoring devices and a gateway device, (e.g. tablet or smart phone) which transmits physiological data, answers to questions, and messages to Beacon Clinical Care Access (Beacon CCA) for review by healthcare providers. Beacon is a flexible and intuitive software application that helps clinicians prioritize patient care, allows for early intervention and facilitates communication with patients in their home.
“We see this clearance as a major milestone in helping make chronic care more convenient and less disruptive for patients,” said Danna Kehm, Managing Director of HealthInterlink. “Regulatory clearance of our software shows that it performs equivalently to a traditional bulky monitor and helps us move towards our bigger vision of reimagining chronic care with mobile devices in a mHealth world.” HealthInterlink will commence commercialization in the U.S. immediately for the Beacon application and is continuing to develop other applications where the system can be utilized to enhance remote patient monitoring.
“Beacon shows our commitment to our customers’ needs and our desire to continually enhance and improve our remote patient monitoring software. We are always striving for better outcomes and value for patients and providers,” said Kehm.
HealthInterlink is an innovative medical software company specializing in remote patient monitoring. Our mission is to provide the most flexible, cost-effective solutions for the collection and delivery of remote health information. Our flagship product, Beacon, is a flexible, intuitive software application that monitors, communicates and manages patients in their homes easily and effectively. Beacon incorporates FDA cleared, wireless patient monitoring devices and a gateway device (e.g. tablet or smart phone) which transmits physiological data, answers to questions, and messages to healthcare providers. For more information, visit http://www.healthinterlink.com.